全文获取类型
收费全文 | 3352篇 |
免费 | 189篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 99篇 |
妇产科学 | 63篇 |
基础医学 | 488篇 |
口腔科学 | 62篇 |
临床医学 | 239篇 |
内科学 | 722篇 |
皮肤病学 | 79篇 |
神经病学 | 277篇 |
特种医学 | 286篇 |
外国民族医学 | 1篇 |
外科学 | 426篇 |
综合类 | 61篇 |
预防医学 | 235篇 |
眼科学 | 47篇 |
药学 | 267篇 |
中国医学 | 11篇 |
肿瘤学 | 156篇 |
出版年
2022年 | 29篇 |
2021年 | 40篇 |
2020年 | 26篇 |
2019年 | 35篇 |
2018年 | 53篇 |
2017年 | 42篇 |
2016年 | 60篇 |
2015年 | 69篇 |
2014年 | 87篇 |
2013年 | 103篇 |
2012年 | 136篇 |
2011年 | 151篇 |
2010年 | 127篇 |
2009年 | 112篇 |
2008年 | 131篇 |
2007年 | 131篇 |
2006年 | 121篇 |
2005年 | 120篇 |
2004年 | 109篇 |
2003年 | 124篇 |
2002年 | 112篇 |
2001年 | 120篇 |
2000年 | 115篇 |
1999年 | 85篇 |
1998年 | 56篇 |
1997年 | 55篇 |
1996年 | 47篇 |
1995年 | 45篇 |
1994年 | 36篇 |
1993年 | 32篇 |
1992年 | 50篇 |
1991年 | 37篇 |
1990年 | 55篇 |
1989年 | 60篇 |
1988年 | 66篇 |
1987年 | 65篇 |
1986年 | 62篇 |
1985年 | 50篇 |
1984年 | 31篇 |
1983年 | 37篇 |
1982年 | 31篇 |
1981年 | 24篇 |
1980年 | 28篇 |
1979年 | 39篇 |
1978年 | 41篇 |
1977年 | 24篇 |
1976年 | 26篇 |
1975年 | 27篇 |
1973年 | 21篇 |
1971年 | 21篇 |
排序方式: 共有3552条查询结果,搜索用时 15 毫秒
71.
Hoffmann R Radke PW Ortlepp JR Haager PK Blindt R Iofina E Franke A Langenberg R Weber C Hanrath P 《The American journal of cardiology》2004,94(12):1548-1550
Intravascular ultrasound studies were performed at angiographic follow-up on 121 native coronary lesions treated with 1 bare metal stent (n = 50), high-dose dexamethasone-eluting stents (n = 18), non-polymer-based paclitaxel-eluting stents (n = 18), or sirolimus-eluting stents (n = 35). Paclitaxel- and sirolimus-eluting stents reduced mean intimal hyperplasia thickness compared with bare metal stents by 49% and 90% (p = 0.048 and p <0.001), respectively, whereas mean intimal hyperplasia thickness treated with dexamethasone-eluting stents was similar to those lesions treated with bare metal stents. 相似文献
72.
Impairment of antipyrine clearance in humans by propranolol 总被引:5,自引:0,他引:5
The effect of propranolol on antipyrine clearance in humans was evaluated in six healthy volunteers who received single 1.4 to 1.5 g doses of intravenous antipyrine on two occasions. The first (control) antipyrine trial was without concurrent drug administration; the second trial was done during treatment with therapeutic doses of propranolol (40 mg every 4 to 6 hours). Antipyrine elimination half-life (t1/2), volume of distribution (Vd), and total clearance were determined after each trial. In all subjects isoproterenol sensitivity decreased markedly during propranolol treatment, indicating a high degree of beta blockade produced by the drug. Mean antipyrine t1/2 during the propranolol treatment period was significantly prolonged, and total clearance significantly reduced, over the control values. Twenty-four-hour urinary excretion of 4-hydroxyantipyrine, the major metabolite of antipyrine, likewise was reduced from 23.6% of the dose on the control trial to 14.8% of the dose during propranolol coadministration (0.1 less than P less than 0.2). Vd however, was nearly identical during both trials (0.62 L/kg). Thus propranolol prolongs the half-life and reduces the clearance or biotransformation rate of antipyrine, a drug whose clearance is independent of hepatic blood flow. Propranolol may influence the activity of hepatic microsomal enzymes responsible for drug hydroxylation. 相似文献
73.
Molecular cloning and amino acid sequence of human plakoglobin, the common junctional plaque protein. 总被引:44,自引:4,他引:44 下载免费PDF全文
74.
Deininger M Pönisch W Krahl R Leiblein S Edel E Lange T Fiedler F Freund M Franke A Pasold R von Grünhagen U Herold M Dölken G Hoffmann FA Uhle R Schultze W Steglich J Schwarzer A Richter P Winkelmann C Kettner E Dachselt K Subert R Schwalbe E Doepper J Helbig W Niederwieser D;East German Study Group Haematology/Oncology 《Bone marrow transplantation》2001,27(11):1125-1132
Mobilised peripheral blood stem cells are widely used for autografting in patients with chronic myeloid leukaemia (CML) and it is generally thought that a high proportion of Ph-negative progenitor cells in the graft is desirable. We report here the results of 91 stem cell mobilisations performed with various chemotherapy regimens followed by G-CSF. We show that mobilisation of Ph-negative cells is possible after diagnosis as well as in advanced stages of the disease. The yield of Ph-negative cells is highly dependent on the chemotherapy regimen: while the combination of idarubicin and cytarabin for 3-5 days (IC3-5) mobilised Ph-negative cells in most patients, high-dose cyclophosphamide was ineffective. Mobilisation of Ph-negative progenitor cells after IC3 was at least as effective as after IC5; however, less apheresis sessions were required, and toxicity was much reduced after IC3. Compared to historical controls, IC was equally effective as the widely used ICE/miniICE (idarubicin, cytarabin, etoposide) protocol. No correlation was found between graft quality and the cytogenetic response to subsequent treatment with interferon-alpha. We conclude that IC3 is an effective and well-tolerated regimen for mobilising Ph-negative cells that compares well with more aggressive approaches such as IC5 and ICE/miniICE. 相似文献
75.
Estienne V Duthoit C Costanzo VD Lejeune PJ Rotondi M Kornfeld S Finke R Lazarus JH Feldt-Rasmussen U Franke WG Smyth P D'Herbomez M Conte-Devolx B Persani L Carella C Jourdain JR Izembart M Toubert ME Pinchera A Weetman A Sapin R Carayon P Ruf J 《European journal of endocrinology / European Federation of Endocrine Societies》1999,141(6):563-569
OBJECTIVE: TGPO autoantibodies (aAbs) that bind simultaneously to thyroglobulin (Tg) and thyroperoxidase (TPO) are present in the serum of patients with autoimmune thyroid diseases (AITD) and have been found to differ from monospecific Tg and TPO aAbs. To obtain further insights on the prevalence defined as the rate of occurrence and significance of TGPO aAbs in a large population, we carried out a collaborative study involving 15 European teams. METHODS: Serum samples from 3122 patients with various thyroid and non-thyroid diseases and normal subjects were assayed using a novel TGPO aAb detection kit. This test was designed so that TGPO aAbs are trapped between the Tg-coated solid phase and the soluble TPO labeled with a radioiodinated monoclonal antibody. RESULTS: Only three out of the 220 normal subjects (prevalence of 1.4%) were found to have positive TGPO aAb levels, which were mainly observed in the patients with AITD: the group of patients suffering from Hashimoto's thyroiditis had a TGPO aAb prevalence of 40.5% (n=437 patients), those with Graves' disease, a prevalence of 34.6% (n=645) and those with post-partum thyroiditis, 16.0% (n=243). Among the non-AITD patients with positive TGPO aAb levels, the TGPO aAb prevalence ranged from 20.7% among those with thyroid cancer (n=246) to 0% among those with toxic thyroid nodules (n=47). Among the patients with non-thyroid diseases, the TGPO aAb prevalence ranged from 9.8% in the case of Biermer's pernicious anemia (n=78) to 0% in that of premature ovarian failure (n=44). It is worth noting that the groups showing the highest TGPO aAb prevalence also contained the patients with the highest TGPO aAb titers. Statistical comparisons between the TGPO aAb prevalences in the various groups showed that TGPO aAb could be used as a parameter to distinguish between the groups of Hashimoto's and Graves' patients and between the women with post-partum thyroiditis and the post-partum women with only Tg and/or TPO aAb established during early pregnancy. Unexpectedly, the correlations between TGPO aAbs and Tg and TPO aAbs were found to depend mainly on the assay kit used. CONCLUSION: High TGPO aAb titers are consistently associated with AITD but the reverse was not found to be true. TGPO aAbs are a potentially useful tool, however, for establishing Hashimoto's diagnosis, and would be worth testing in this respect with a view to using them for routine AITD investigations. 相似文献
76.
We appreciate the interest of Drs. Manescal and Dubourg in ourarticle and we are indebted for their constructive comments.In our study most of the data were 相似文献
77.
78.
Toonen EJ Barrera P Radstake TR van Riel PL Scheffer H Franke B Coenen MJ 《Annals of the rheumatic diseases》2008,67(12):1663-1669
Over the last years microarray technologies have generated new perspectives for the high-throughput analysis of biological systems. Nowadays, it is possible to monitor thousands of genes in a single experiment. This molecular profiling technology combined with standardised and validated clinical measurements can allow a more precise characterisation of a patient's phenotype, and may lead to the design of therapeutic protocols and procedures better tailored to an individual patient's needs. In this report we provide an overview of expression profiling studies in rheumatoid arthritis (RA). RA is a chronic inflammatory disease in which both genetic and environmental factors are involved. The precise molecular mechanisms underlying RA are not fully understood. A systematic literature search revealed nine array-based expression profiling studies in patients with RA. Findings from these studies were compared with those of linkage and genome-wide association (GWA) studies. Although we observed many differences in study design, analysis and interpretation of results between the different studies, we extracted two sets of genes: (1) those differentially expressed in more than one study, and (2) genes differentially expressed in at least one of the reviewed studies and present in RA linkage or GWA loci. We suggest that both sets of genes include interesting candidate genes for further study in RA. 相似文献
79.
Alexey A. Shadrin PhD Sören Mucha PhD David Ellinghaus PhD Mary B. Makarious BSc Cornelis Blauwendraat PhD Ashwin A.K. Sreelatha MSc Antonio Heras-Garvin PhD Jinhui Ding PhD Monia Hammer PhD Alexandra Foubert-Samier MD Wassilios G. Meissner MD Olivier Rascol PhD Anne Pavy-Le Traon MD Oleksandr Frei PhD Kevin S. O'Connell PhD Shahram Bahrami PhD Stefan Schreiber MD Wolfgang Lieb MD Martina Müller-Nurasyid PhD Ulf Schminke MD Georg Homuth PhD Carsten O. Schmidt PhD Markus M. Nöthen MD Per Hoffmann PhD Christian Gieger PhD Gregor Wenning MD for the European Multiple System Atrophy Study Group J. Raphael Gibbs PhD Andre Franke PhD John Hardy PhD Nadia Stefanova PhD Thomas Gasser MD Andrew Singleton PhD Henry Houlden MD Sonja W. Scholz MD Ole A. Andreassen PhD Manu Sharma PhD 《Movement disorders》2021,36(2):449-459
80.
John T. Petroff II Ankita Isor Satyanarayana M. Chintala Carolyn J. Albert Jacob D. Franke David Weinstein Sara M. Omlid Christopher K. Arnatt David A. Ford Ryan D. McCulla 《RSC advances》2020,10(44):26553
A beneficial property of photogenerated reactive oxygen species (ROS) is the capability of oxidant generation within a specific location or organelle inside a cell. Dibenzothiophene S-oxide (DBTO), which is known to undergo a photodeoxygenation reaction to generate ground state atomic oxygen [O(3P)] upon irradiation, was functionalized to afford localization within the plasma membrane of cells. The photochemistry, as it relates to oxidant generation, was studied and demonstrated that the functionalized DBTO derivatives generated O(3P). Irradiation of these lipophilic O(3P)-precursors in the presence of LDL and within RAW 264.7 cells afforded several oxidized lipid products (oxLP) in the form of aldehydes. The generation of a 2-hexadecenal (2-HDEA) was markedly increased in irradiations where O(3P) was putatively produced. The substantial generation of 2-HDEA is not known to accompany the production of other ROS. These cellular irradiation experiments demonstrate the potential of inducing oxidation with O(3P) in cells.Lipophilic O(3P)-precursors generate 2-hexadecenal upon UV-irradiation. 相似文献